Condition category
Mental and Behavioural Disorders
Date applied
28/09/2007
Date assigned
28/09/2007
Last edited
05/03/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Ravi Lingam

ORCID ID

Contact details

Regional Department of Psychotherapy
Claremont House
Off Framlington Place
Newcastle upon Tyne
NE2 4AA
United Kingdom
+44 (0)191 2824547
Ravi.Lingam@nmht.nhs.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0573173216

Study information

Scientific title

Psychoanalytically oriented brief group treatment for borderline personality disorder: a randomised controlled trial

Acronym

Study hypothesis

Is psychoanalytically oriented brief group psychotherapy an effective treatment for borderline personality disorder?

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Mental and Behavioural Disorders: Borderline personality disorder

Intervention

The intervention to be researched is a Psychoanalytic Brief Group treatment, it is a 20-week outpatient programme. There are two treatment groups. Each group will consist of 8 subjects. The control will consist of a waiting list control. This will be treatment-as-usual for the subjects and will consist of their ongoing existing treatment in psychiatric or primary care services.

Intervention type

Behavioural

Phase

Drug names

Primary outcome measures

Is a psychoanalytically-oriented brief group therapy an effective treatment for borderline personality disorder?

Secondary outcome measures

Reduction in self harm and suicidal ideation, reduction in symptoms and improvement in function and finally the cost implication of this treatment.

Overall trial start date

09/01/2006

Overall trial end date

09/01/2008

Reason abandoned

Eligibility

Participant inclusion criteria

Clinical diagnosis of Borderline Personality Disorder meeting DSM-IV criteria and clinical judgment of capacity of psychological mindedness.

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

32

Participant exclusion criteria

Clinical risk assessment that there may be a significant acute risk of suicide or harm to others, that there is an active psychotic illness, or that there is use of alcohol or drugs to the extent that the subject cannot engage with the treatment.

Recruitment start date

09/01/2006

Recruitment end date

09/01/2008

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Regional Department of Psychotherapy
Newcastle upon Tyne
NE2 4AA
United Kingdom

Sponsor information

Organisation

Record Provided by the NHSTCT Register - 2007 Update - Department of Health

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Funder name

Northumberland, Tyne and Wear NHS Trust

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

NHS R&D Support Funding

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes